Rising Rate of urological disorders, increasing urological cancer incidents and high investment by market players in Healthcare sector

Urology Devices Market is predicted to reach USD 48.5 billion at a CAGR of 4% during the forecast period:

Market Research Future (MRFR) has published a cooked research report on the “Global Urology Devices Market” that contains information from 2023 to 2032. The Urology Devices market is estimated to register a CAGR of 4% during the forecast period of 2023 to 2032.

MRFR recognizes the following companies as the key players in the global Urology Devices market— Olympus Corporation, Medtronic, Boston Scientific Corporation, KARL STORZ GmbH & Co. KG, R. Bard, Dornier MedTech (Germany), Stryker (US), Fresenius Medical Care AG & Co. KGaA (Germany).

Urology Devices Market Highlights

The global Urology Devices market is accounted to register a CAGR of 4% during the forecast period and is estimated to reach USD 48.5 billion by 2032.

The urology devices market refers to the industry that deals with medical devices used in the diagnosis, treatment, and management of urinary system disorders and conditions. These devices include catheters, stents, endoscopes, and other instruments used in urological procedures.

Segment Analysis

The global Urology Devices market has been segmented based on Type, Application, Technology and End-User.

On the basis of Type, the market is segmented into dialysis equipment, urinary stone treatment devices, endoscopy devices, benign prostatic hyperplasia treatment devices, and urinary incontinence & pelvic organ prolapse. The market revenue for urology devices was dominated by endoscopic devices in 2022, which can be ascribed to the rising prevalence of urolithiasis and the strong demand for disposable cystoscopes, particularly in developed nations.

Based on Application, the global Urology Devices market has been segmented into Minimally Invasive Surgery and Robotic Surgery. In 2022, the minimally invasive surgery category dominated the industry. According to projections, the terminal side segment will experience the largest growth between 2023 and 2030, with an increase in urological problem patients choosing minimally invasive procedures over more invasive ones.

Based on Technology, the global Urology Devices market has been segmented into benign prostatic hyperplasia, prostate cancer, urinary stones, and urinary incontinence. Due to the higher risk of developing urine incontinence in diabetic patients, the urinary incontinence Urology Devices category had the majority share of the market revenue for Urology Devices in 2022.

Based on End-User, the global Urology Devices market has been segmented into hospitals and ambulatory services. Due to the increasing number of patient visits at hospitals for urology-related illnesses, the hospitals and clinics segment, which held the market's top spot in 2022, is anticipated to grow at the fastest rate throughout the forecast period, 2023-2032.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Urology Devices Market Research Report

Regional Analysis

The global Urology Devices market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Urology Devices market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Urology Devices market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Urology Devices market comprises of Middle East, Africa, and Latin America.

The North America Urology Devices Market dominated this market in 2022 The market is expected to reach USD 16.71 billion in 2022 and is expected to expand at a significant CAGR during the study period, driven by factors such as the rising number of kidney disease patients, the rise in patient visits for treatment and diagnosis, and the importance of market players in the region.

Additionally, the second-largest market share for Urology Devices is held by Europe. Increasing patient visits for treatment and diagnostics, an increase in kidney disease patients, and the presence of major market participants in the area are all projected to fuel the market.

 Additionally, the region's fastest growing urological device market is Germany, while the UK market held the greatest market share.

Due to increased emphasis on improving growing awareness regarding the diagnosis of urology disorders, healthcare infrastructure, and rising product launches by businesses throughout Japan, China, and India, the Asia-Pacific Urology Devices Market is projected to develop at the fastest CAGR from 2023 to 2030. Additionally, rising government spending on creating cutting-edge healthcare infrastructure is probably going to increase the use of ventilators in the region's hospitals, which will support market expansion.

Key Findings of the Study                                                                                                                                       

• The global Urology Devices market is expected to reach USD 48.03 billion by 2030, at a CAGR of 4.00% during the forecast period.


• The North America Urology Devices Market dominated this market in 2022 The market is expected to reach USD 16.71 billion in 2022 and is expected to expand at a significant CAGR during the study period.


• Based on Application, In 2022, the minimally invasive surgery category dominated the industry.


• Olympus Corporation, Medtronic, Boston Scientific Corporation, KARL STORZ GmbH & Co. KG, R. Bard, Dornier MedTech (Germany), Stryker (US), Fresenius Medical Care AG & Co. KGaA (Germany).